Discover 1,359 paid clinical trials in Athens, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,359
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
for
Sickle Cell Disease Vaso-occlusive Crisis
Location: Atlanta GA, Louisville KY, Greenville NC, Cincinnati OH,
Sponsor: CSL Behring
Sex: All
Age: 12+
Code: NCT06699849
Phase2, Recruiting
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
for
Sickle Cell Disease
Location: Atlanta GA, Flowood MS, Richmond VA, Columbus OH,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT07224360
Phase2, Recruiting
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
for
Status Epilepticus
Location: Atlanta GA, Cincinnati OH, Charlottesville VA,
Sponsor: University of Virginia
Sex: All
Age: 1+
Code: NCT06907173
Phase3, Recruiting
Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)
for
Glanzmann Thrombasthenia
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 0+
Code: NCT07136857
Phase2, Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Atlanta GA, Birmingham AL, Durham NC, Cincinnati OH,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 21
Code: NCT04870944
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Atlanta GA, Asheville NC, Knoxville TN, Birmingham AL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT07466316
Phase3, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: Atlanta GA, Knoxville TN, Birmingham AL, Nashville TN,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT07022678
Phase3, Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Atlanta GA, Greenville SC, Asheville NC, Columbia SC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase2, Recruiting
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
for
Malignant Glioma
Location: Atlanta GA, Greenville SC, Columbia SC, Knoxville TN,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 21
Code: NCT05099003
Phase1, Phase2, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Atlanta GA, Greenville SC, Macon GA, Augusta GA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase2, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Atlanta GA, Greenville SC, Columbia SC, Knoxville TN,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase2, Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
for
Hematopoietic and Lymphatic System Neoplasm,
Location: Atlanta GA, Greenville SC, Knoxville TN, Savannah GA,
Sponsor: Children's Oncology Group
Sex: All
Age: 15 - 20
Code: NCT06410209
Phase2, Recruiting
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: Atlanta GA, Greenville SC, Columbia SC, Charlotte NC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 21
Code: NCT06064097
Phase2, Recruiting
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
Location: Atlanta GA, Greenville SC, Augusta GA, Columbia SC,
Sponsor: Children's Oncology Group
Sex: All
Age: 6 - 39
Code: NCT05702645
Recruiting
Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
for
High-grade Glioma, Medulloblastoma,
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 2 - 25
Code: NCT06624371
Phase1, Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Atlanta GA, Greenville SC, Columbia SC, Knoxville TN,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase3, Recruiting
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
for
Heart Failure, Left Ventricular Systolic Dysfunction